Literature DB >> 29302468

The EUROASPIRE surveys: lessons learned in cardiovascular disease prevention.

Kornelia Kotseva1,2.   

Abstract

The Joint European Societies (JES) guidelines on cardiovascular disease (CVD) prevention published in 1994, 1998, 2003, 2007, 2012 and 2016 defined lifestyle and risk factors targets for patients with coronary or other atherosclerotic disease and people at high risk of developing CVD. Guideline implementation in Europe has been evaluated with four cross-sectional EUROASPIRE surveys starting in mid-1990s. The results showed poor lifestyle and risk factor management in patients with CHD and in high CVD risk people with high prevalences of smoking, obesity, central obesity and diabetes. The control of blood pressure, lipids and glucose was far from optimal. A comparison across the recent three surveys provided a unique description of time trends for secondary prevention over a period of 14 years. The results showed adverse lifestyle trends, a substantial increase in obesity, central obesity and diabetes. Despite significant improvement of blood pressure and lipid control many patients were not reaching the risk factor goals and there was no change in glucose control. Comparing the most recent two surveys, there were no major differences in lifestyle and risk factor management in people at high risk of developing CVD. A new approach to CVD prevention integrating primary and secondary prevention into a modern preventive cardiology programme, focusing on lifestyle and risk factor management is required, in order to reduce the risk of CVD events and improve quality of life in patients with CHD and those at high risk of developing CVD.

Entities:  

Keywords:  Cardiovascular prevention; EUROASPIRE; audit; guidelines implementation

Year:  2017        PMID: 29302468      PMCID: PMC5752826          DOI: 10.21037/cdt.2017.04.06

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  27 in total

1.  Prevalence of Ideal Cardiovascular Health Among Adults in the United States.

Authors:  Adnan Younus; Ehimen C Aneni; Erica S Spatz; Chukwuemeka U Osondu; Sameer Shaharyar; Lara Roberson; Shozab S Ali; Oluseye Ogunmoroti; Rameez Ahmad; Janisse Post; Theodore Feldman; Wasim Maziak; Arthur S Agatston; Emir Veledar; Khurram Nasir
Journal:  J Am Coll Cardiol       Date:  2015-10-06       Impact factor: 24.094

2.  EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events.

Authors: 
Journal:  Eur Heart J       Date:  1997-10       Impact factor: 29.983

3.  European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Authors:  Ian Graham; Dan Atar; Knut Borch-Johnsen; Gudrun Boysen; Gunilla Burell; Renata Cifkova; Jean Dallongeville; Guy De Backer; Shah Ebrahim; Bjørn Gjelsvik; Christoph Herrmann-Lingen; Arno Hoes; Steve Humphries; Mike Knapton; Joep Perk; Silvia G Priori; Kalevi Pyorala; Zeljko Reiner; Luis Ruilope; Susana Sans-Menendez; Wilma Scholte Op Reimer; Peter Weissberg; David Wood; John Yarnell; Jose Luis Zamorano; Edmond Walma; Tony Fitzgerald; Marie Therese Cooney; Alexandra Dudina; Alec Vahanian; John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Christian Funck-Brentano; Gerasimos Filippatos; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; Jóse Luis Zamorano; Attila Altiner; Enzo Bonora; Paul N Durrington; Robert Fagard; Simona Giampaoli; Harry Hemingway; Jan Hakansson; Sverre Erik Kjeldsen; mogens Lytken Larsen; Giuseppe Mancia; Athanasios J Manolis; Kristina Orth-Gomer; Terje Pedersen; Mike Rayner; Lars Ryden; Mario Sammut; Neil Schneiderman; Anton F Stalenhoef; Lale Tokgözoglu; Olov Wiklund; Antonis Zampelas
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-09

4.  EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.

Authors:  Kornelia Kotseva; David Wood; Dirk De Bacquer; Guy De Backer; Lars Rydén; Catriona Jennings; Viveca Gyberg; Philippe Amouyel; Jan Bruthans; Almudena Castro Conde; Renata Cífková; Jaap W Deckers; Johan De Sutter; Mirza Dilic; Maryna Dolzhenko; Andrejs Erglis; Zlatko Fras; Dan Gaita; Nina Gotcheva; John Goudevenos; Peter Heuschmann; Aleksandras Laucevicius; Seppo Lehto; Dragan Lovic; Davor Miličić; David Moore; Evagoras Nicolaides; Raphael Oganov; Andrzej Pajak; Nana Pogosova; Zeljko Reiner; Martin Stagmo; Stefan Störk; Lale Tokgözoğlu; Dusko Vulic
Journal:  Eur J Prev Cardiol       Date:  2015-02-16       Impact factor: 7.804

5.  Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events.

Authors: 
Journal:  Lancet       Date:  2001-03-31       Impact factor: 79.321

6.  Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme.

Authors: 
Journal:  Eur Heart J       Date:  2001-04       Impact factor: 29.983

7.  EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.

Authors:  Kornelia Kotseva; David Wood; Guy De Backer; Dirk De Bacquer; Kalevi Pyörälä; Ulrich Keil
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2009-04

8.  Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.

Authors:  Kornelia Kotseva; Dirk De Bacquer; Catriona Jennings; Viveca Gyberg; Guy De Backer; Lars Rydén; Philippe Amouyel; Jan Bruthans; Renata Cifkova; Jaap W Deckers; Johan De Sutter; Zlatko Fraz; Ian Graham; Irena Keber; Seppo Lehto; David Moore; Andrzej Pajak; David Wood
Journal:  Glob Heart       Date:  2016-03-16

9.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

10.  Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network.

Authors:  Pantaleo Giannuzzi; Pier Luigi Temporelli; Roberto Marchioli; Aldo Pietro Maggioni; Gianluigi Balestroni; Vincenzo Ceci; Carmine Chieffo; Marinella Gattone; Raffaele Griffo; Carlo Schweiger; Luigi Tavazzi; Stefano Urbinati; Franco Valagussa; Diego Vanuzzo
Journal:  Arch Intern Med       Date:  2008-11-10
View more
  11 in total

1.  Anti-diabetic agents and heart health: how to use new diabetes medications in a global strategy for the prevention of cardiovascular complications in type 2 diabetes.

Authors:  Carmine Gazzaruso; Adriana Coppola; Tiziana Montalcini; Colomba Falcone
Journal:  Ann Transl Med       Date:  2018-05

2.  Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients.

Authors:  Chi-Chang Chen; Pallavi B Rane; Dionne M Hines; Jeetvan Patel; David J Harrison; Rolin L Wade
Journal:  Ther Clin Risk Manag       Date:  2018-12-13       Impact factor: 2.423

3.  Adherence to prescription guidelines and achievement of treatment goals among persons with coronary heart disease in Tromsø 7.

Authors:  Elisabeth Pedersen; Beate Hennie Garcia; Kjell H Halvorsen; Anne Elise Eggen; Henrik Schirmer; Marit Waaseth
Journal:  BMC Cardiovasc Disord       Date:  2021-01-21       Impact factor: 2.298

4.  Ambulatory blood pressure monitoring and blood pressure control in patients with coronary artery disease-A randomized controlled trial.

Authors:  Oscar Hägglund; Per Svensson; Cecilia Linde; Jan Östergren
Journal:  Int J Cardiol Hypertens       Date:  2020-12-20

5.  Chinese patients' clinical and psychosocial outcomes in the 6 months following percutaneous coronary intervention.

Authors:  Xia Liu; Adeleke Fowokan; Sherry L Grace; Biao Ding; Shu Meng; Xiu Chen; Yinghua Xia; Yaqing Zhang
Journal:  BMC Cardiovasc Disord       Date:  2021-03-23       Impact factor: 2.298

6.  Prevalence of metabolic syndrome, its risk factors and associated lifestyles in Myanmar adult people: A community based cross-sectional study.

Authors:  Su Su Maw
Journal:  Metabol Open       Date:  2021-10-13

Review 7.  Risk Prediction of Cardiovascular Events by Exploration of Molecular Data with Explainable Artificial Intelligence.

Authors:  Annie M Westerlund; Johann S Hawe; Matthias Heinig; Heribert Schunkert
Journal:  Int J Mol Sci       Date:  2021-09-24       Impact factor: 5.923

8.  Primary Prevention of Cardiovascular Risk in Lithuania-Results from EUROASPIRE V Survey.

Authors:  Gediminas Urbonas; Lina Vencevičienė; Leonas Valius; Ieva Krivickienė; Linas Petrauskas; Gintarė Lazarenkienė; Justina Karpavičienė; Gabrielė Briedė; Emilė Žučenkienė; Karolis Vencevičius
Journal:  Medicina (Kaunas)       Date:  2020-03-18       Impact factor: 2.430

9.  Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies.

Authors:  Felix Mahfoud; Michel Azizi; Sebastian Ewen; Atul Pathak; Christian Ukena; Peter J Blankestijn; Michael Böhm; Michel Burnier; Gilles Chatellier; Isabelle Durand Zaleski; Guido Grassi; Michael Joner; David E Kandzari; Ajay Kirtane; Sverre E Kjeldsen; Melvin D Lobo; Thomas F Lüscher; John William McEvoy; Gianfranco Parati; Patrick Rossignol; Luis Ruilope; Markus P Schlaich; Atif Shahzad; Faisal Sharif; Andrew S P Sharp; Horst Sievert; Massimo Volpe; Michael A Weber; Roland E Schmieder; Costas Tsioufis; William Wijns
Journal:  Eur Heart J       Date:  2020-04-21       Impact factor: 29.983

10.  Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women's Ischemia Syndrome Evaluation).

Authors:  Tara Sedlak; Romana Herscovici; Galen Cook-Wiens; Eileen Handberg; Janet Wei; Chrisandra Shufelt; Vera Bittner; Steven E Reis; Nathaniel Reichek; Carl Pepine; C Noel Bairey Merz
Journal:  J Am Heart Assoc       Date:  2020-04-09       Impact factor: 6.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.